Preeclampsia: An update

Acta Anaesthesiologica Belgica

Volumn 65, Issue 4, 2014, Pages 137-149

  Lambert, G ^a,b   Brichant, J F ^b   Hartstein, G ^b   Bonhomme, V ^a,b   Dewandre, P Y ^a,b  

^a Centre Hospitalier Regional de La Citadelle   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Hemodynamic; Hypertension; Management; Preeclampsia; Pregnancy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CARBETOCIN; CLONIDINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM SULFATE; METHYLDOPA; NICARDIPINE; NIFEDIPINE; NITROUS OXIDE; OXYTOCIN; PLACENTAL GROWTH FACTOR; PROPANOL; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CESAREAN SECTION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DELIVERY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG MECHANISM; ECLAMPSIA; ELEVATED BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; EPIDEMIOLOGICAL DATA; EXPECTANT PARENT; FETAL WELL BEING; FETUS LUNG MATURATION; FETUS OUTCOME; FLUID THERAPY; FOLLOW UP; GENERAL ANESTHESIA; GESTATIONAL AGE; HEADACHE; HELLP SYNDROME; HEMODYNAMICS; HUMAN; INTRAUTERINE GROWTH RETARDATION; LABOR; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEUROLOGIC DISEASE; OBSTETRIC ANESTHESIA; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA DISORDER; POSTPARTUM HYPERTENSION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PUERPERIUM; REGIONAL ANESTHESIA; RISK FACTOR; SEIZURE; SYSTOLIC BLOOD PRESSURE; THROMBOSIS PREVENTION; UTERINE CERVIX RIPENING; VISUAL DISORDER; FEMALE; OBSTETRIC ANALGESIA; PRE-ECLAMPSIA; PREGNANCY;

ANALGESIA, OBSTETRICAL; ANESTHESIA, OBSTETRICAL; ANTIHYPERTENSIVE AGENTS; FEMALE; FLUID THERAPY; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84921722921     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Cantwell R., Clutton-Brock T., Cooper G., Dawson A., Drife J., Garrod D., Harper A., Hulbert D., Lucas S., McClure J., Millward-Sadler H., Neilson J., Nelson-Piercy C., Norman J., O'Herlihy C., M. Oates, J. Shakespeare, M. de Swiet, C. Williamson, V. Beale, M. Knight, C. Lennox, A. Miller, D. Parmar, J. Rogers. Springett A., Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom, BJOG, 118 Suppl 1, 1-203, 2011.
2. Khan K. S., Wojdyla D., Say L., Gulmezoglu A. M., Van Look P. F., WHO analysis of causes of maternal death: a systematic review, LANCET, 367, 1066-74, 2006.
3. Leanos-Miranda A., Marquez-Acosta J., Romero-Arauz F., Cardenas-Mondragon G. M., Rivera-Leanos R., Isordia-Salas I., Ulloa-Aguirre A., Protein: creatinine ratio in random urine samples is a reliable marker of increased 24-hour protein excretion in hospitalized women with hypertensive disorders of pregnancy, CLIN. CHEM., 53, 1623-8, 2007.
4. The American College of Obstetricians and Gynecologists-Task Force on Hypertension in Pregnancy. Hypertension in pregancy. In: LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA. 2013.
5. Homer C. S., Brown M. A., Mangos G., Davis G. K., Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension, J. HYPERTENS., 26, 295-302, 2008.
6. Magee L.A., Helewa M., Moutquin J.M., von Dadelszen P.; Hypertension Guideline Committee: Strategic Training Initiative in Research in the Reproductive Health Sciences. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J OBSTET. GYNAECOL CAN., 30, S1-48, 2008.
7. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy, NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE CLINICAL GUIDELINE, 107, 2010.
8. Lam C., Lim K. H., Karumanchi S. A., Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia, HYPERTENSION, 46, 1077-85, 2005.
9. Warrington J. P., George E. M., Palei A. C., Spradley F. T., Granger J. P., Recent advances in the understanding of the pathophysiology of preeclampsia, HYPERTENSION, 62, 666-73, 2013.
10. Bosio P. M., McKenna P. J., Conroy R., O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy, OBSTET. GYNECOL., 94, 978-84, 1999.
11. Brichant J. F., Brichant G., Dewandre P. Y., Foidart J. M.; Collége national des gynécologues et obstétriciens; Société française de medécine périnatale; Société française de néonatalogie, Société française de anesthésie et de réanimation, [Circulatory and respiratory problems in preeclampsia], ANN. FR. ANESTH. REANIM., 29, e91-5, 2010.
12. Dennis A. T., Castro J., Carr C., Simmons S., Permezel M., Royse C. Haemodynamics in women with untreated preeclampsia, ANAESTHESIA, 67, 1105-18, 2012.
13. Easterling T. R., Benedetti T. J., Schmucker B. C., Millard S. P., Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study, OBSTET. GYNECOL., 76, 1061-9, 1990.
14. Easterling T.R., Watts D.H., Schmucker B.C., Benedetti T. J., Measurement of cardiac output during pregnancy: validation of Doppler technique and clinical observations in preeclampsia, OBSTET. GYNECOL., 69, 845-50, 1987.
15. Elvan-Taspinar A., Franx A., Bots M. L., Bruinse H. W., Koomans H. A., Central hemodynamics of hypertensive disorders in pregnancy, AM. J. HYPERTENS., 17, 941-6, 2004.
16. Valensise H., Vasapollo B., Gagliardi G., Novelli G. P., Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease, HYPERTENSION, 52, 873-80, 2008.
17. Langesaeter E., Is it more informative to focus on cardiac output than blood pressure during spinal anesthesia for cesarean delivery in women with severe preeclampsia?, ANESTHESIOLOGY, 108, 771-2, 2008.
18. Dyer R. A., James M. F., Maternal hemodynamic monitoring in obstetric anesthesia, ANESTHESIOLOGY, 109, 765-7, 2008.
19. Nuthalapaty F. S., Beck M. M., Mabie W. C., Complications of central venous catheters during pregnancy and postpartum: a case series, AM. J. OBSTET. GYNECOL., 201, 311 e1-5, 2009.
20. Dennis A. T., Transthoracic echocardiography in obstetric anaesthesia and obstetric critical illness, INT. J. OBSTET. ANESTH., 20, 160-8, 2011.
21. Akkermans J., Diepeveen M., Ganzevoort W., van Montfrans G. A., Westerhof B. E., Wolf H., Continuous non-invasive blood pressure monitoring, a validation study of Nexfin in a pregnant population, HYPERTENS. PREGNANCY, 28, 230-42, 2009.
22. Norwitz E.R., http://www.uptodate.com/contents/eclampsia, July, 2014.
23. Cipolla M. J., Cerebrovascular function in pregnancy and eclampsia, HYPERTENSION, 50, 14-24, 2007.
24. Cipolla M. J., Sweet J. G., Chan S. L., Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia, J. APPL. PHYSIOL. (1985). 110, 329-39, 2011.
25. Brewer J., Owens M. Y., Wallace K., Reeves A. A., Morris R., Khan M., LaMarca B., Martin J.N., Jr., Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia, AM. J. OBSTET. GYNECOL., 208, 468.e1-6, 2013.
26. Wagner S. J., Acquah L. A., Lindell E. P., Craici I. M., Wingo M. T., Rose C. H., White W. M., August P., Garovic V. D., Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control, MAVO CLIN. PROC, 86, 851-6, 2011.
27. Lowe S. A., Brown M. A., Dekker G. A., Gatt S., McLintock C. K., McMahon L. P., Mangos G., Moore M. P., Muller P., Paech M., Walters B.; Society of Obstetric Medicine of Australia and New Zealand, Guidelines for the management of hypertensive disorders of pregnancy 2008, AUST. N. Z. J. OBSTET. GYNAECOL., 49, 242-6, 2009.
28. Mostello D., Kallogjeri D., Tungsiripat R., Leet T., Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy. body mass index, paternity, and interval between births, AM. J. OBSTET. GYNECOL., 199, 55.e1-7, 2008.
29. Rana S., Karumanchi S. A., Lindheimer M. D., Angiogenic factors in diagnosis, management, and research in preeclampsia, HYPERTENSION, 63, 198-202, 2014.
30. Rana S., Powe C. E., Salahuddin S., Verlohren S., Perschel F. H., Levine R. J., Lim K. H., Wenger J. B., Thadhani R., Karumanchi S. A., Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia, CIRCULATION, 125, 911-9, 2012.
31. Afshani N., Moustaqim-Barrette A., Biccard B. M., Rodseth R. N., Dyer R. A., Utility of B-type natriuretic peptides in preeclampsia: a systematic review, INT. J. OBSTET. ANESTH., 22, 96-103, 2013.
32. r. Societe francaise. d'anesthesie et de, f. College national des gynecologues et obstetriciens, p. Societe francaise de medecine in Societe francaise de, [Multidisciplinary management of severe pre-eclampsia (PE). Experts' guidelines 2008. Societe francaise d'anesthesie et de reanimation. College national des gynecologues et obstetriciens francais. Societe francaise de medecine perinatale. Societe francaise de neonatalogie], ANN. FR. ANESTH. REANIM., 28, 275-81, 2009.
33. Abalos E., Duley L., Steyn D. W., Antihypertensive drug therapy for mild to moderate hypertension during pregnancy, COCHRANE DATABASE SYST. REV., 2, CD002252, 2014.
34. Publications Committee, Society for Maternal-Fetal Medicine, Sibai B. M., Evaluation and management of severe preeclampsia before 34 weeks' gestation, AM. J. OBSTET. GYNECOL., 205, 191-8, 2011.
35. Dennis A. T., Management of pre-eclampsia: issues for anaesthetists, ANAESTHESIA, 67, 1009-20, 2012.
36. Duley L., Meher S., Jones L., Drugs for treatment of very high blood pressure during pregnancy, COCHRANE DATABASE SYST REV, 7, CD001449, 2013.
37. Sibai B. M., Barton J. R., Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications, AM. J. OBSTET. GYNECOL., 196, 514 e1-9, 2007.
38. Woudstra D. M., Chandra S., Hofmeyr G. J., Dowswell T., Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy, COCHRANE DATABASE SYST REV, CD008148, 2010.
39. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial, LANCET, 345, 1455-63, 1995.
40. Duley L., Gulmezoglu A. M., Henderson-Smart D. J., Chou D., Magnesium sulphate and other anticonvulsants for women with pre-eclampsia, COCHRANE DATABASE SYST. REV., CD000025, 2010.
41. Euser A. G., Bullinger L., Cipolla M. J., Magnesium sulphate treatment decreases blood-brain barrier permeability during acute hypertension in pregnant rats, EXP. PHYSIOL., 93, 254-61, 2008.
42. Euser A. G., Cipolla M. J., Magnesium sulfate for the treatment of eclampsia: a brief review, STROKE, 40, 1169-75, 2009.
43. Magee L. A., Miremadi S., Li J., Cheng C., Ensom M. H., Carleton B., Cote A. M., von Dadelszen P., Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia, AM. J. OBSTET. GYNECOL., 193, 153-63, 2005.
44. Dennis A. T., Solnordal C. B., Acute pulmonary oedema in pregnant women. ANAESTHESIA, 67, 646-59, 2012.
45. Melchiorre K., Sutherland G.R., Baltabaeva A., Liberati M., Thilaganathan B., Maternal cardiac dysfunction and remodeling in women with preeclampsia at term, HYPERTENSION, 57, 85-93, 2011.
46. Blackwell S.C., Redman M.E., Tomlinson M., Landwehr J. B., Jr., Tuynman M., Gonik B., Sorokin Y., Cotton D. B., Labor induction for the preterm severe pre-eclamptic patient: is it worth the effort?, J. MATERN. FETAL. MED., 10, 305-11, 2001.
47. Moen V., Dahlgren N., Irestedt L., Severe neurological complications after central neuraxial blockades in Sweden 1990-1999, ANESTHESIOLOGY, 101, 950-9, 2004.
48. Barker P., Callander C. C., Coagulation screening before epidural analgesia in pre-eclampsia, ANAESTHESIA, 46, 64-7, 1991.
49. Leduc L., Wheeler J. M., Kirshon B., Mitchell P., Cotton D. B., Coagulation profile in severe preeclampsia, OBSTET. GYNECOL., 79, 14-8, 1992.
50. American Society of Anesthesiologists Task Force on Obstetric Anesthesia, Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia, ANESTHESIOLOGY, 106, 843-63, 2007.
51. Aya A. G., Mangin R., Vialles N., Ferrer J. M., Robert C., Ripart J., de La Coussaye J. E., Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison, ANESTH. ANALG., 97, 867-72, 2003.
52. Dyer R. A., Piercy J. L., Reed A. R., Lombard C. J., Schoeman L. K., James M. F., Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia, ANESTHESIOLOGY, 108, 802-11, 2008.
53. Hood D.D., Curry R., Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: a retrospective survey, ANESTHESIOLOGY, 90, 1276-82, 1999.
54. Huang C. J., Fan Y. C., Tsai P. S., Differential impacts of modes of anaesthesia on the risk of stroke among preeclamptic women who undergo Caesarean delivery: a population-based study, BR. J. ANAESTH., 105, 818-26, 2010.
55. Visalyaputra S., Rodanant O., Somboonviboon W., Tantivitayatan K., Thienthong S., Saengchote W., Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia a prospective randomized, multicenter study, ANESTH. ANALG., 101, 862-8, table of contents, 2005.
56. Berends N., Teunkens A., Vandermeersch E., Van de Velde M., A randomized trial comparing low-dose combined spinal-epidural anesthesia and conventional epidural anesthesia for cesarean section in severe preeclampsia, ACTA ANAESTHESIOL. BELG., 56, 155-62, 2005.
57. Carvalho J.C., Balki M., Kingdom J., Windrim R., Oxytocin requirements at elective cesarean delivery: a dose-finding study, OBSTET. GYNECOL., 104, 1005-10, 2004.
58. Langesaeter E., Rosseland L. A., Stubhaug A., Haemodynamic effects of oxytocin in women with severe preeclampsia, INT. J. OBSTET. ANESTH., 20, 26-9, 2011.
59. Langesaeter E., Rosseland L. A., Stubhaug A., Hemodynamic effects of oxytocin during cesarean delivery, INT. J. GYNAECOL. OBSTET., 95, 46-7, 2006.
60. Pisani I., Tiralongo G. M., Gagliardi G., Scala R. L., Todde C., Frigo M. G., Valensise H., The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section, PREGNANCY HYPERTENSION: AN INTERNATIONAL JOURNAL OF WOMEN'S CARDIOVASCULAR HEALTH, 2, 139-142, 2012.
61. Dyer R. A., van Dyk D., Dresner A., The use of uterotonic drugs during caesarean section, INT. J. OBSTET. ANESTH., 19, 313-9, 2010.
62. Sibai B. M., Etiology and management of postpartum hvpertension-preeclampsia, AM. J. OBSTET. GYNECOL., 206, 470-5, 2012.
63. Magee L., von Dadelszen P., Prevention and treatment of postpartum hypertension, COCHRANE DATABASE SYST. REV., 4, CD00435L2013.
64. McDonald S. D., Malinowski A., Zhou Q., Yusuf S., Devereaux P. J., Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses, AM. HEART J., 156, 918-30, 2008.